# EA2222 (NCT05863195)

> Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05863195
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: ECOG-ACRIN Cancer Research Group
- Conditions: Metastatic Colorectal Carcinoma; Metastatic Malignant Neoplasm in the Liver; Stage IV Colorectal Cancer AJCC v8; Unresectable Colorectal Carcinoma
- Interventions: Bevacizumab; Capecitabine; Cetuximab; Computed Tomography; Floxuridine; Fluorouracil; Implantation; Intrahepatic Infusion Procedure; Irinotecan; Leucovorin; Magnetic Resonance Imaging; Oxaliplatin; Panitumumab; Single Photon Emission Computed Tomography
- Enrollment: 408
- Primary outcome: Overall survival (OS)

## Indexed commentary on EA2222 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 45
- Podcasts: 4
- YouTube: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=ea2222-nct05863195

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05863195", "email": "<work email>"}; the inbox owner confirms by the emailed link.